Nordic-Neurostim ApS: Financial statements 2022
CVR: 38049909
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Nordic-Neurostim ApS (CVR 38049909) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -561,752 and a net result of DKK -454,342 compared with DKK -1,098,410 the year before. Equity in the 2022 report amounted to DKK -1,666,147.
- Gross Profit
- DKK -561,752
- Profit/Loss
- DKK -454,342
- Equity
- DKK -1,666,147
- Total Assets
- DKK 1,337,492
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -562K | -454K | -1.7M | - |
| 2021 | - | -1.4M | -1.1M | -1.2M | - |
| 2020 | - | -1.1M | -927K | -113K | - |
| 2019 | - | 33K | -16K | 117K | - |
| 2018 | - | 249K | 184K | 132K | - |
Official annual report
Keep an eye on Nordic-Neurostim ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Nordic-Neurostim ApS has published its annual report for 2021. Gross profit came to DKK -1,390,077, and the net result was DKK -1,098,410.
About Nordic-Neurostim ApS
Nordic-Neurostim ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christian Peter Christiansen. The board consists of Morten Kristian Haugland (chair) and Christian Peter Christiansen. The company is owned by MORTEN HAUGLAND HOLDING ApS, Varebex ApS and Medodan Consulting ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 89,658 and a net result of DKK -33,430 compared with DKK -10,264 the year before. Equity in the 2025 report amounted to DKK -1,858,514.
